Chemed Corp - CHE STOCK NEWS

Chemed (NYSE: CHE) has announced its schedule for releasing third-quarter 2024 financial results. The company will disclose its earnings on Tuesday, October 29, 2024, after the New York Stock Exchange closes. Following this, Chemed will host a conference call and webcast on Wednesday, October 30, 2024, at 10 a.m. ET to discuss the quarterly results and provide a business update.

Investors and analysts can access the live webcast through Chemed's investor relations website or via a specific hosting link. Teleconference registration is also available. A taped replay of the call will be accessible approximately two hours after its conclusion through Chemed's investor relations website.

Chemed , headquartered in Cincinnati, Ohio, operates two subsidiaries: VITAS Healthcare, the largest provider of end-of-life hospice care in the US, and Roto-Rooter, the leading national provider of plumbing and drain cleaning services.

Chemed (NYSE:CHE) has announced a 25% increase in its quarterly cash dividend, raising it from 40 cents to 50 cents per share. The dividend will be payable on August 30, 2024, to shareholders of record as of August 12, 2024. This marks Chemed's 213th consecutive quarterly dividend in its 53 years as a public company. The previous dividend increase was in August 2023, from 38 cents to 40 cents per share.

Chemed operates two wholly owned subsidiaries: VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the United States.

Chemed (NYSE: CHE) reported strong Q2 2024 financial results. Consolidated revenue rose 7.6% to $595.9 million, while GAAP diluted EPS increased 32.5% to $4.65. Adjusted diluted EPS jumped 34.1% to $5.47. VITAS segment revenue grew 16.7% to $374.6 million, driven by a 14.4% increase in average daily census and 11.0% rise in admissions. Conversely, Roto-Rooter posted a 5.0% decline in revenue to $221.3 million alongside a 9.2% drop in adjusted EBITDA. Chemed ended the quarter with $222.9 million in cash and no debt. Additionally, the company repurchased 100,000 shares worth $55.8 million. Guidance for 2024 has been revised upward, anticipating VITAS revenue to grow by 16.3%-17.3% and Roto-Rooter revenue to decline by 4.0%-5.0%. Full-year EPS is projected to range between $23.55 and $23.80.

Chemed (NYSE: CHE) will release its second-quarter financial results for 2024 on July 24, following the close of trading on the NYSE.

The company will hold a conference call and webcast at 10 a.m. ET on July 25 to discuss the results and provide an update on its business. Participants can access the live webcast through Chemed's investor relations website or by registering for the teleconference. A replay of the call will be available approximately two hours after its conclusion.

Chemed, headquartered in Cincinnati, operates VITAS Healthcare, the largest U.S. provider of end-of-life hospice care, and Roto-Rooter, the leading provider of plumbing and drain cleaning services.

Chemed (NYSE: CHE) will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024, at 9:00 a.m. (ET). The event will be held at the New York Marriott Marquis, with a live webcast available on the Chemed website. The webcast replay will be accessible for 90 days post-event. Chemed, headquartered in Cincinnati, Ohio, operates two subsidiaries: VITAS Healthcare, the largest provider of end-of-life hospice care in the U.S., and Roto-Rooter, the leading provider of plumbing and drain cleaning services in the U.S.

Chemed (NYSE:CHE) held its 2024 annual stockholders’ meeting, where 10 directors were elected, and PricewaterhouseCoopers LLP was ratified as the independent accountant for 2024. Stockholders approved the executive compensation but voted against a proposal on termination pay. Subsequently, Chemed's Board declared a quarterly cash dividend of 40 cents per share, payable on June 18, 2024, to stockholders of record as of May 30, 2024. This marks the 212th consecutive quarterly dividend in the company's 53-year history as a public entity. Chemed operates VITAS Healthcare, the nation's largest hospice care provider, and Roto-Rooter, a leading plumbing and drain cleaning service provider.

Chemed (CHE) will present at the Bank of America Securities Health Care Conference 2024 on May 14, 2024. The presentation will be webcast live and available for replay on the Chemed website. Chemed operates VITAS Healthcare and Roto-Rooter, with a focus on end-of-life hospice care and plumbing services.

Chemed (NYSE: CHE) reported positive financial results for the first quarter of 2024, with a 5.2% revenue increase to $589.2 million. GAAP Diluted EPS increased by 18.4% to $4.24, while Adjusted Diluted EPS rose by 21.5% to $5.20. VITAS segment saw growth in Net Patient Revenue, ADC, and Admissions. Roto-Rooter segment experienced a decrease in revenue but maintained a 51.9% gross margin. Chemed had total cash of $313.4 million with no debt. Management provided a full-year 2024 earnings per diluted share guidance range of $23.30 to $23.70.

VITAS Healthcare , a subsidiary of Chemed , completed the purchase of hospice operations and an assisted living facility from Covenant Health and Community Services for $85 million. The transaction covers Florida and Alabama markets and closed on April 17, 2024.